ArticleBMC biotechnology2025
Synthesis of nano silver particles using extracellular polysaccharide of Pseudoduganella armeniaca ZMN-3: antibacterial activity, antibacterial mechanism and antibacterial application as coating.
Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study focused on the antibacterial activity, mechanism and application of Pseudoduganella armeniaca ZMN - 3 extracellular polysaccharide nano silver. Extracellular polysaccharide nano silver was prepared by chemical synthesis and characterized by UV - Vis spectroscopy, Fourier transform infrared spectroscopy, X - ray diffraction, X - ray photoelectron spectroscopy, scanning electron microscopy and transmission electron microscopy. The antibacterial effects of extracellular polysaccharide nano silver on two common pathogens were investigated by agar well diffusion method and broth dilution method. The results showed that extracellular polysaccharide nano silver had significant inhibitory effects on Escherichia coli and Staphylococcus aureus. In addition, by SEM and TEM observation, the conductivity, the leakage of nucleic acids and proteins, the release of reducing sugars, the ATP content, and the alkaline phosphatase level were also measured. The study results indicated that extracellular polysaccharide nano silver could cause the leakage of large biomolecules such as nucleic acids and proteins, reduce the release of sugars, increase ATP content, and lead to the leakage of alkaline phosphatase, ultimately resulting in bacterial death. Finally, the application of extracellular polysaccharide nano silver in antibacterial coating was studied. Antibacterial coating achieved an impressive inhibition rate of 99% against both Escherichia coli and Staphylococcus aureus and could effectively resist bacterial adhesion within 7 days. This study provides a theoretical basis for the potential application of Pseudoduganella armeniaca ZMN - 3 extracellular polysaccharide nano silver in the antibacterial field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.